Key result
Converting enzyme inhibitors failed to block angiotensin I conversion in the hamster cheek pouch, with 68% of applied angiotensin I converted to angiotensin II regardless of inhibitor presence.
Answers are grounded in this paper and cite their sources.
Kininase II (angiotensin I-converting enzyme) is generally accepted to be the enzyme responsible for the conversion of angiotensin I (A I) to angiotensin II (A II). This study examined the response of the microvasculature of the hamster cheek pouch to the local application of A I, A II, and the renin substrate, tetradecapeptide (TDP). A I and TDP caused a localized vasoconstriction that was not blocked by converting enzyme inhibitors (CEI: BPF5a for A I and BPF5a and the nonapeptide inhibitor for TDP). However, both the A II antagonist [Sar1, Ala8]angiotensin II and the antiserum to A II blocked completely the A I- and TDP-induced vasoconstriction. Sixty-eight percent of the applied A I was converted to A II in the presence of CEI as well as in its absence. It is concluded that the vasculature of the hamster cheek pouch converts significant amounts of A I to A II by a route that does not involve kininase II.
No takes yet. Share an insight, caveat, or question.
Cornish et al. (1979) studied Microvascular conversion of angiotensin I to angiotensin II in the hamster cheek pouch. Local application of angiotensin I, angiotensin II, and tetradecapeptide with converting enzyme inhibitors vs. Absence of converting enzyme inhibitors, or blockade with [Sar1, Ala8]angiotensin II and A II antiserum was evaluated on Conversion of applied angiotensin I to angiotensin II and localized vasoconstriction. Converting enzyme inhibitors failed to block angiotensin I conversion in the hamster cheek pouch, with 68% of applied angiotensin I converted to angiotensin II regardless of inhibitor presence.
Synapse has enriched 10 related papers. Consider them for comparative context: